Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.950.640.600.400.40

What is the latest Fixed Capital/Sales ratio of GLAND PHARMA ?

The latest Fixed Capital/Sales ratio of GLAND PHARMA is 0.95 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.95
Mar20240.64
Mar20230.60
Mar20220.40
Mar20210.40

How is Fixed Capital/Sales of GLAND PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.95
48.44
Mar2024 0.64
6.67
Mar2023 0.6
50.00
Mar2022 0.4
0.00
Mar2021 0.4 -

Other Financial Ratios of GLAND PHARMA


Compare Fixed Capital/Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,971.5 Cr 5.3% -8% 7.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,647.0 Cr 0.1% -0.4% 0.6% Stock Analytics
DIVIS LABORATORIES ₹157,862.0 Cr -1.1% -7.1% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,846.0 Cr 0.2% -4.5% 30.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,720.0 Cr 0.2% -4% 6% Stock Analytics
CIPLA ₹98,795.9 Cr 0% -9.1% -18.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

5.3%

-8%

7.2%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses